Dr. Momont studies how a virus known as the bovine leukemia virus affects B-cell leukemia and lymphoma, which are types of blood cancers. His research specifically looks at tiny RNA molecules, called microRNAs, that are produced by this virus. These microRNAs are particularly intriguing because they make up about 40% of all microRNAs found in leukemia cells, suggesting they have a powerful influence on the disease. By examining these viral microRNAs, Dr. Momont aims to uncover how they silence important genes and contribute to the development and worsening of these cancers.
Key findings
Viral microRNAs constitute approximately 40% of all microRNAs found in B-cell leukemia and lymphoma cells, indicating their dominance in these cancers.
The presence of these microRNAs reveals a new mechanism through which B-cell leukemia may progress, by silencing key genes that would normally help control cell growth.
Understanding these viral microRNAs has the potential to lead to new diagnostic and therapeutic approaches for patients with B-cell leukemia and lymphoma.
Frequently asked questions
Does Dr. Momont study B-cell leukemia?
Yes, Dr. Momont's research specifically focuses on B-cell leukemia and lymphoma.
What are microRNAs and why are they important?
MicroRNAs are tiny molecules that regulate gene expression. In Dr. Momont's work, viral microRNAs from the bovine leukemia virus are crucial because they can silence genes involved in cancer progression.
How does Dr. Momont's research help patients?
His findings could lead to better understanding and new treatments for patients suffering from B-cell leukemia and lymphoma.
Publications in plain English
Deep sequencing reveals abundant noncanonical retroviral microRNAs in B-cell leukemia/lymphoma.
2013
Proceedings of the National Academy of Sciences of the United States of America
Rosewick N, Momont M, Durkin K, Takeda H, Caiment F +7 more
Plain English This study investigated how a specific virus, the bovine leukemia virus, produces tiny RNA molecules called microRNAs in B-cell leukemia or lymphoma. Researchers found that these viral microRNAs make up about 40% of all microRNAs in leukemia cells and play an important role in the disease by silencing key genes in the cells. Understanding these microRNAs can help clarify how this type of cancer develops and progresses.
Who this helps: This research benefits patients with B-cell leukemia and lymphoma, as well as their doctors.